Almirall, S.A.

MSE:ALM.MC

8.57 (EUR) • At close September 6, 2024
Bedrijfsnaam Almirall, S.A.
Symbool ALM.MC
Munteenheid EUR
Prijs 8.57
Beurswaarde 1,829,429,330
Dividendpercentage 0%
52-weken bereik 7.85 - 10.08
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Carlos Gallardo Piqué
Website https://www.almirall.com

An error occurred while fetching data.

Over Almirall, S.A.

Almirall, S.A., a biopharmaceutical company, engages in the research, development, manufacture, and sale of skin-health related medicines in Europe, the United States, and internationally. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, androgenic alopecia, psoriasis, onychomycosis, oncodermatology, acne, and orphan indications, as well as for

Vergelijkbare Aandelen

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited logo

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

T14.SI

1.87 USD

Dimed S.A. Distribuidora de Medicamentos logo

Dimed S.A. Distribuidora de Medicamentos

PNVL3.SA

10.06 BRL

Raffles Medical Group Ltd logo

Raffles Medical Group Ltd

BSL.SI

0.895 SGD

Orpea SA logo

Orpea SA

ORP.PA

12.312 EUR

Vetoquinol SA logo

Vetoquinol SA

VETO.PA

91.6 EUR

Centro de Imagem Diagnósticos S.A. logo

Centro de Imagem Diagnósticos S.A.

AALR3.SA

15.3 BRL

Summerset Group Holdings Limited logo

Summerset Group Holdings Limited

SUM.NZ

9.72 NZD

Haw Par Corporation Limited logo

Haw Par Corporation Limited

H02.SI

10.45 SGD

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)